FDA to regulate genetically engineered animals (Nature)
Drug agency opens door to market approval for transgenic animals.

FDA Issues Warning Letters To Ranbaxy Laboratories Ltd., And An Import Alert For Drugs From Two Ranbaxy Plants In India (Medical News Today)
The Food and Drug Administration (FDA) issued two Warning Letters to Ranbaxy Laboratories Ltd., of the Republic of India, and an Import Alert for generic drugs produced by Ranbaxy's Dewas and Paonta Sahib plants in India. The Warning Letters identify the agency's concerns about deviations from U.S.